Unigene deal

On April 25, four of investor Victory Park Credit's affiliates acquired Unigene's oral drug delivery assets in a public auction in exchange for the satisfaction and discharge of $15 million outstanding under senior secured notes. The assets include Unigene's Peptelligence drug delivery and recombinant manufacturing platforms. The affiliates, which comprised Victory Park Credit Opportunities, Victory Park Credit Opportunities Intermediate Fund, VPC Fund II and VPC Intermediate Fund II, then transferred the assets to Victory Park Capital affiliate Enteris BioPharma Inc. ...